2008
DOI: 10.1016/j.metabol.2007.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Preclinical vascular damage in white postmenopausal women: the relevance of osteoprotegerin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 25 publications
1
13
0
Order By: Relevance
“…32,33 It is unclear whether osteoprotegerin should be considered to be an independent risk factor for cardiovascular diseases 11 or to be a defense mechanism for atherosclerotic progression. 30 There are several limitations to our study. The first limitation relates to its cross-sectional design, which implies that no causal inferences can be drawn.…”
Section: Discussionmentioning
confidence: 94%
“…32,33 It is unclear whether osteoprotegerin should be considered to be an independent risk factor for cardiovascular diseases 11 or to be a defense mechanism for atherosclerotic progression. 30 There are several limitations to our study. The first limitation relates to its cross-sectional design, which implies that no causal inferences can be drawn.…”
Section: Discussionmentioning
confidence: 94%
“…20,21) There have been very few studies on the relationship between the OPG and ADMA levels. 38,39) However, no previous studies found any relationship between the OPG and ADMA levels and the CIMT. The present study demonstrated, for the first time, that increased OPG levels were significantly related to the ADMA levels and the mCIMT in patients with CAD, thus suggesting that increased OPG levels were associated with endothelial function in patients with CAD.…”
Section: Elevated Opg Levels and Coronary Artery Diseases And Cimtmentioning
confidence: 98%
“…Decreased OPG levels were found in diabetic obese subjects [55,75], and insulin resistance in healthy obese subjects is associated with decreased serum OPG levels [63], whereas weight reduction therapy resulted in further decrease in OPG serum concentrations [75]. However, Siepi et al [76] suggested that OPG levels do not seem to be related with abdominal obesity in diabetic patients. Moreover, studies by Gannagé-Yared et al [77] indicated that OPG plasma levels did not differ between obese and non-obese subjects but OPG was statistically higher in 18 obese diabetic subjects compared with nondiabetics, although, after adjustment for age, OPG was not related to BMI in obese subjects.…”
Section: Opg and Obesity Lipid Profile And Metabolic Syndrome In Diamentioning
confidence: 99%